Clinical Trial Update: Comparative Effectiveness and Cost-Benefit Analysis of Vancomycin Powder in High Risk Spine Surgery Patients [NA]

View source ↗

Summary

The clinical trial NCT01566422 evaluating vancomycin powder to prevent surgical site infections in high-risk spine surgery patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infection

Drugs mentioned

• Vancomycin powder (vancomycin)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Surgical Site Infection | NA | Status: WITHDRAWN